Ophthalmic Viscosurgical Devices Market Size & Share Report, 2032

Ophthalmic Viscosurgical Devices Market Size - By Product (Dispersive, Cohesive, Combined), By Application (Cataract Surgery, Vitreoretinal Surgery, Canaloplasty, Refractive Surgery, Keratoplasty), By End-use (Hospitals, Clinics) & Forecast, 2023 – 2032 

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Industry coverage

1.2&nbsp;&nbsp;&nbsp; Market scope &amp; definition

1.3&nbsp;&nbsp;&nbsp; Base estimates &amp; calculations

1.3.1&nbsp;&nbsp;&nbsp; Data collection

1.4&nbsp;&nbsp;&nbsp; Forecast parameters

1.5&nbsp;&nbsp;&nbsp; COVID-19 impact analysis at global level

1.6&nbsp;&nbsp;&nbsp; Data validation

1.7&nbsp;&nbsp;&nbsp; Data Sources

1.7.1&nbsp;&nbsp;&nbsp; Primary

1.7.2&nbsp;&nbsp;&nbsp; Secondary

1.7.2.1&nbsp;&nbsp;&nbsp;Paid sources

1.7.2.2&nbsp;&nbsp;&nbsp;Unpaid sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Ophthalmic viscosurgical devices industry 360&ordm; synopsis, 2018 &ndash; 2032

2.2&nbsp;&nbsp;&nbsp; Business trends

2.3&nbsp;&nbsp;&nbsp; Regional trends

2.4&nbsp;&nbsp;&nbsp; Product trends

2.5&nbsp;&nbsp;&nbsp; Application trends

2.6&nbsp;&nbsp;&nbsp; End-use trends

Chapter 3&nbsp;&nbsp;&nbsp;Ophthalmic Viscosurgical Devices Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp;Rapidly growing geriatric population

3.2.1.2&nbsp;&nbsp;&nbsp;Increasing incidence of ophthalmic and ocular condition

3.2.1.3&nbsp;&nbsp;&nbsp;Expanding base of diabetic patients worldwide

3.2.1.4&nbsp;&nbsp;&nbsp;Growing access to ophthalmic care facilities

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp;Availability of alternative treatment procedures

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.3.1&nbsp;&nbsp;&nbsp; By product

3.3.3&nbsp;&nbsp;&nbsp; By application

3.3.4&nbsp;&nbsp;&nbsp; By end use

3.4&nbsp;&nbsp;&nbsp; COVID- 19 impact analysis

3.5&nbsp;&nbsp;&nbsp; Regulatory landscape

.3.6.1 &nbsp;&nbsp;&nbsp; U.S.

3.6.2&nbsp;&nbsp;&nbsp; Europe

3.6&nbsp;&nbsp;&nbsp; Technology landscape

3.7&nbsp;&nbsp;&nbsp; Reimbursement scenario

3.8&nbsp;&nbsp;&nbsp; Future market trends

3.9&nbsp;&nbsp;&nbsp; Gap analysis

3.10&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.11&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2022

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis, 2022

4.3&nbsp;&nbsp;&nbsp; Company market share analysis, 2022

4.4&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.5&nbsp;&nbsp;&nbsp; Vendor matrix analysis

4.6&nbsp;&nbsp;&nbsp; Strategy dashboard, 2022

Chapter 5&nbsp;&nbsp;&nbsp;Ophthalmic Viscosurgical Devices Market Size and Forecast, By Product (USD Million)

5.1&nbsp;&nbsp;&nbsp; Key trends, by product

5.2&nbsp;&nbsp;&nbsp; Dispersive

5.3&nbsp;&nbsp;&nbsp; Cohesive

5.4&nbsp;&nbsp;&nbsp; Combined

Chapter 6&nbsp;&nbsp;&nbsp;Ophthalmic Viscosurgical Devices Market Size and Forecast, By Application (USD Million)

6.1&nbsp;&nbsp;&nbsp; Key trends, by application

6.2&nbsp;&nbsp;&nbsp; Cataract surgery

6.3&nbsp;&nbsp;&nbsp; Vitreoretinal surgery

6.4&nbsp;&nbsp;&nbsp; Canaloplasty

6.5&nbsp;&nbsp;&nbsp; Refractive surgery

6.6&nbsp;&nbsp;&nbsp; Keratoplasty

6.7&nbsp;&nbsp;&nbsp; Others

Chapter 7&nbsp;&nbsp;&nbsp;Ophthalmic Viscosurgical Devices Market Size and Forecast, By End-use (USD Million)

7.1&nbsp;&nbsp;&nbsp; Key trends, by end-use

7.2&nbsp;&nbsp;&nbsp; Hospitals

7.3&nbsp;&nbsp;&nbsp; Clinics

7.4&nbsp;&nbsp;&nbsp; Others

Chapter 8&nbsp;&nbsp;&nbsp;Ophthalmic Viscosurgical Devices Market Size and Forecast, By Region (USD Million)

8.1&nbsp;&nbsp;&nbsp; Key trends, by region

8.2&nbsp;&nbsp;&nbsp; North America

8.2.1&nbsp;&nbsp;&nbsp; U.S.

8.2.2&nbsp;&nbsp;&nbsp; Canada

8.3&nbsp;&nbsp;&nbsp; Europe

8.3.1&nbsp;&nbsp;&nbsp; Germany

8.3.2&nbsp;&nbsp;&nbsp; UK

8.3.3&nbsp;&nbsp;&nbsp; France

8.3.4&nbsp;&nbsp;&nbsp; Spain

8.3.5&nbsp;&nbsp;&nbsp; Italy

8.3.6&nbsp;&nbsp;&nbsp; Poland

8.3.7&nbsp;&nbsp;&nbsp; Sweden

8.3.8&nbsp;&nbsp;&nbsp; The Netherlands

8.4&nbsp;&nbsp;&nbsp; Asia Pacific

8.4.1&nbsp;&nbsp;&nbsp; Japan

8.4.2&nbsp;&nbsp;&nbsp; China

8.4.3&nbsp;&nbsp;&nbsp; India

8.4.4&nbsp;&nbsp;&nbsp; Australia

8.4.5&nbsp;&nbsp;&nbsp; South Korea

8.4.6&nbsp;&nbsp;&nbsp; Thailand

8.4.7&nbsp;&nbsp;&nbsp; Indonesia

8.4.8&nbsp;&nbsp;&nbsp; Philippines

8.5&nbsp;&nbsp;&nbsp; Latin America

8.5.1&nbsp;&nbsp;&nbsp; Brazil

8.5.2&nbsp;&nbsp;&nbsp; Mexico

8.5.3&nbsp;&nbsp;&nbsp; Argentina

8.5.4&nbsp;&nbsp;&nbsp; Columbia

8.5.5&nbsp;&nbsp;&nbsp; Chile

8.5.6&nbsp;&nbsp;&nbsp; Peru

8.6&nbsp;&nbsp;&nbsp; MEA

8.6.1&nbsp;&nbsp;&nbsp; South Africa

8.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

8.6.3&nbsp;&nbsp;&nbsp; UAE

8.6.4&nbsp;&nbsp;&nbsp; Israel

8.6.5&nbsp;&nbsp;&nbsp; Turkey

8.6.6&nbsp;&nbsp;&nbsp; Iran

Chapter 9&nbsp;&nbsp;&nbsp;Company Profiles

9.1&nbsp;&nbsp;&nbsp; Alcon

9.2&nbsp;&nbsp;&nbsp; Amring Pharmaceuticals

9.3&nbsp;&nbsp;&nbsp; Bausch &amp; Lomb Incorporated

9.4&nbsp;&nbsp;&nbsp; Bohus Biotech AB

9.5&nbsp;&nbsp;&nbsp; Carl Zeiss Meditec AG

9.6&nbsp;&nbsp;&nbsp; CIMA Technology Inc

9.7&nbsp;&nbsp;&nbsp; Johnson &amp; Johnson Surgical Vision, Inc

9.8&nbsp;&nbsp;&nbsp; Maxigen Biotech Inc

9.9&nbsp;&nbsp;&nbsp; Precision Lens

9.10&nbsp;&nbsp;&nbsp; Rayner Intraocular Lenses Ltd.

9.11&nbsp;&nbsp;&nbsp; Sidapharm

&nbsp;&nbsp;&nbsp;

Ophthalmic Viscosurgical Devices Market

Inquiry Before Buying